GJ Menon, SA Vernon - British Journal of Ophthalmology, 2006 - bjo.bmj.com References 1 Mazur MT, Shultz JJ, Myers JL. Granular cell tumor.
Immunohistochemical analysis of 21 benign and one malignant tumor. Arch Pathol
Lab Med 1990;114:692–6. 2 Luthra CL, Doxanas MT, Green WR. Lesions of the ... Cited by 3 - Related articles - All 7 versions
N Shoji - Expert Review of Ophthalmology, 2007 - ingentaconnect.com Brinzolamide is indicated for the reduction of intraocular pressure (IOP) in
eyes with ocular hypertension or open-angle glaucoma. Brinzolamide is an
effective inhibitor of carbonic anhydrase and lowers IOP by suppressing ... Cited by 2 - Related articles - BL Direct - All 3 versions
M Iester - Expert Opin. Pharmacother., 2008 - informahealthcare.com Primary open-angle glaucoma is a multifactorial optic neuropathy characterized
by the progressive loss of retinal ganglion cells and their axons. However, the
primary risk factor is elevated intraocular pressure (IOP), which can ... Cited by 2 - Related articles - BL Direct - All 6 versions
[CITATION] Does glaucoma medication influence the diameter of the retinal arteriole in the human eyes
P Kothy, G Hollo - A pilot study using the retinal vessel analyser). Aca … Cited by 2 - Related articles
W Franks - Current Medical Research and Opinion®, 2006 - informahealthcare.com Wendy Franks a and the brinzolamide Study Group† ... Address for
correspondence: Wendy Franks, Moorfields Eye Hospital, 265 City Road, London,
EC1V 2PD, UK. email: wendy.franks@moorfields.nhs.uk Key words: Brinzolamide ... Cited by 3 - Related articles - BL Direct - All 5 versions
[CITATION] Comparison of three months treatment with dorzolamide and brinzolamide on perfusion …
B Siesky, T Lin, L Kagemann, J Smith - International Symposium on Ocular Pharmacology and …, 2006 Cited by 3 - Related articles
[CITATION] The role of blood gases in ocular perfusion
TH Wang, JY Huang, PT Hung, JW Shieh, YF … - Journal of the Formosan Medical Association, 2004 - cat.inist.fr Background and Purpose: Brinzolamide is a new topical carbonic anhydrase
inhibitor for intraocular pressure(IOP) control. It has high inhibitory activity
against human carbonic anhydrase II, which is the key isoenzyme regulating ... Cited by 5 - Related articles - BL Direct - All 5 versions
- ►bmj.com [PDF] JC Zhao, T Chen - British Medical Journal, 2005 - bjo.bmj.com If you have a burning desire to respond to a paper published in the BJO, why not
make use of our ''rapid response'' option? Logon toourwebsite(www.bjophthalmol.
com), find the paper that interests you, and send your response via email ... Cited by 6 - Related articles - All 8 versions
